<DOC>
	<DOCNO>NCT01370161</DOCNO>
	<brief_summary>The purpose study determine whether early use transjugular intrahepatic portosystemic shunt ( TIPS ) Polytetrafluoroethylene ( PTFE ) cover stent able prolong survival cirrhotic patient high risk acute variceal bleeding .</brief_summary>
	<brief_title>Early TIPS With Polytetrafluoroethylene ( PTFE ) Covered Stents High Risk Acute Variceal Bleeding Cirrhotic Patients</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>History cirrhosis ( clinical liver biopsy ) Admission due acute bleed oesophageal gastric ( GOV1 GOV2 ) varices ChildPugh Class C ( ChildPugh score less equal 13 ) ChildPugh class B Signed write informed consent Patients fulfil inclusion criterion Pregnancy breastfeed Confirmed hepatocellular carcinoma follow characteristic : one nodule 5 cm ; 3 great 3 cm Creatinine great 3 mg/dl Terminal hepatic failure ( ChildPugh score great 13 ) Previous treatment TIPS combine pharmacological endoscopic treatment prevent rebleeding Fundal ectopic gastric variceal bleeding ( IGV1 IGV2 ) Portal vein thrombosis cavernoma Congestive heart failure New York Heart Association ( NYHA ) great III medical history pulmonary hypertension Spontaneous recurrent hepatic encephalopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>transjugular intrahepatic portosystemic shunt</keyword>
	<keyword>TIPS</keyword>
	<keyword>variceal bleeding</keyword>
	<keyword>liver cirrhosis</keyword>
	<keyword>hepatitis B</keyword>
</DOC>